MERCK & CO., INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 126.9 USD | +0.92% |
|
+0.59% | +16.44% |
ETFs positioned on Merck & Co., Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 14.34% | 215 M€ | +12.92% | - | |
| 5.61% | 18 M€ | +2.56% | - | |
| 2.85% | 9 M€ | -.--% | - | |
| 2.80% | 2 M€ | -.--% | - | |
| 2.63% | 5 M€ | -72.95% | - | |
| 2.08% | 8 M€ | -.--% | ||
| 1.96% | 16 M€ | -3.37% | ||
| 1.96% | 1 M€ | +11.94% | - | |
| 1.96% | 3 M€ | +7.32% | - | |
| 1.96% | 13 M€ | -.--% | - | |
| 1.95% | 2 M€ | +5.19% | ||
| 1.91% | 120 M€ | +11.28% | - | |
| 1.84% | 487 M€ | +2.88% | ||
| 1.50% | 9 M€ | -4.31% | - | |
| 1.43% | 393 M€ | +4.50% | ||
| 1.40% | 267 M€ | +6.75% | ||
| 1.35% | 2 M€ | +14.69% | - | |
| 1.17% | 13 M€ | -.--% | - | |
| 1.17% | 4 M€ | -.--% | - | |
| 1.17% | 3 M€ | +15.16% | - | |
| 1.13% | 92 M€ | +0.06% | - | |
| 1.08% | 10 M€ | +3.89% | ||
| 1.05% | 36 M€ | -.--% |
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
Pharmaceuticals
Calendar
2024-04-25
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
126.9
USD
Average target price
137.6
USD
Spread / Average Target
+8.38%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +16.44% | 322B | |
| +25.46% | 659B | |
| +25.31% | 557B | |
| -4.86% | 359B | |
| +8.34% | 297B | |
| +7.11% | 215B | |
| +7.39% | 210B | |
| -6.91% | 200B | |
| -8.79% | 149B | |
| -5.59% | 146B |
- Stock Market
- Equities
- MRK Stock
- Funds and ETFs Merck & Co., Inc.
